Mode
Text Size
Log in / Sign up

Primary sclerosing cholangitis

Part of Bile Duct Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for primary sclerosing cholangitis

10 trials tracked for primary sclerosing cholangitis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 115 citations.

10Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 6 Phase 1 3
  1. Phase 3 Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects Completed · 115 cited
  2. Phase 2 A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) Completed
  3. Phase 2 Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) Completed
  4. Phase 2 A Study of NGM282 in Patients With Primary Sclerosing Cholangitis Completed
  5. Phase 2 Vidofludimus Calcium for Primary Sclerosing Cholangitis Completed
  6. Phase 2 PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis Completed
Show 4 more trials
  1. Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Completed
  2. Phase 1 Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT Completed
  3. Phase 1 A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis Completed
  4. Phase 1 Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.